Get startedLog in
    Picture of Sensorion SA logo

    ALSEN — Sensorion SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Sensorion Initiates Safety Study Of Seliforant Versus Meclizine In Evoked Vestibular Imbalance

    Picture of Sensorion SA logoSensorion SA
    24/07/2018 07:15
    July 24 (Reuters) - Sensorion SA  ALSEN.PA :
    * SENSORION INITIATES SAFETY STUDY OF SELIFORANT VERSUS
MECLIZINE
IN EVOKED VESTIBULAR IMBALANCE
    * SENSORION INITIATES SAFETY STUDY OF SELIFORANT VERSUS
MECLIZINE
IN EVOKED VESTIBULAR IMBALANCE
    * SAFETY AND PHARMACODYNAMIC EFFECTS OF SELIFORANT COMPARED
TO
MECLIZINE

Source text for Eikon:  ID:nBwby4Bwja 
Further company coverage:  ALSEN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 7720920;))

    Recent news on Sensorion SA

    See all news